Antitermination in Mycobacterium tuberculosis
Mycobacterium tuberculosis is the leading cause of death from a single infectious agent. The varying efficacy of the BCG vaccine and the emergence of multi-drug resistant strains of M. tuberculosis have made it essential that novel drug and vaccine targets are identified. The antitermination mechani...
Main Author: | Cochrane, Shaun Kevern Twyman |
---|---|
Published: |
University College London (University of London)
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408292 |
Similar Items
-
Design, synthesis and evaluation of UDP-galactopyranose mutase inhibitors as new anti-tuberculosis agents
by: Sadeghi-Khomami, Ali
Published: (2004) -
Design, synthesis and biological evaluation of inhibitors of mycobacterial galactan biosynthesis
by: Cren, Sylvaine
Published: (2005) -
Detection of mycobacterium tuberculosis
by: McNerney, Ruth
Published: (2001) -
Pathogen polymorphisms of mycobacterium tuberculosis
by: Ho, Timothy Boon Leong
Published: (2003) -
Isoniazid resistance in Mycobacterium tuberculosis
by: Tho, Dau Quang
Published: (2012)